Navigation Links
Institutional Shareholder Services (ISS) Recommends Allergan Shareholders Call A Special Meeting Of Shareholders
Date:8/6/2014

whether the board acts in the spirit of good governance to honor their request promptly, or instead engages in additional delaying tactics. Among these, it should be noted, is the possibility the board—having received a valid request from a sufficient number of shareholders who have undertaken the arduous work of complying with the bylaw—then insists on taking the full 120 days it has allotted itself to call the special meeting. As a benchmark, most companies—even Allergan, judging from its track record in calling annual meetings—find 30-45 days sufficient when the need arises."
  • "If what transpires, once a valid request for a special meeting has been submitted, suggests an enduring and irreconcilable difference of opinion about what constitutes "good governance," shareholders may wish to further avail themselves of the opportunity, once a special meeting is finally called, to address the root cause of these governance concerns directly."
  • "Given the substantial premium of the Valeant offer to the undisturbed price of Allergan shares, it may seem wise, as well, to allow the large strategic question —whether it is credible to believe remaining standalone will deliver higher value than selling—to also come to a head at the same meeting."
  • Excerpts from Glass Lewis ReportNoting that investors electing to participate in Pershing Square's Pershing Square's efforts to call a special meeting must satisfy a myriad of significant and ongoing administrative hurdles, while the board can seek to nullify those efforts through a decidedly simpler proxy solicitation process, Glass Lewis notes:

  • "In our opinion, this procedural dichotomy casts a rather dubious light on the seriousness of the board's desire to be responsive to investors. This obstructive process echoes a trend of recalcitrant adherence to progressive corporate governance standards at Allergan, including a period marked by active opposition to sh
    '/>"/>

  • SOURCE Valeant Pharmaceuticals International, Inc.
    Copyright©2014 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10

    Related medicine technology :

    1. Cell Therapeutics Announces Institutional Investor Purchased Additional $15 Million of Convertible Preferred Stock and Warrants to Purchase Common Stock
    2. Global Market for Industrial and Institutional Cleaning Products to Exceed $52 Billion by 2018, Hand Sanitizers Poised to Reach $226.3 Million by 2018
    3. Masimo to Present at Raymond James 34th Annual Institutional Investors Conference
    4. Abaxis, Inc. to Present at the Raymond James 34th Annual Institutional Investor Conference
    5. HeartWare Presentation At Raymond James 34th Annual Institutional Investors Conference To Be Webcast
    6. Abaxis, Inc. to Present at the Sidoti & Company Seventeenth Annual Institutional Investor Forum
    7. Imprimis Pharmaceuticals, Inc. Receives Institutional Review Board (IRB) Approval for its Phase III Clinical Trial Protocol; Phase III Clinical Trial to Begin in 3Q 2013
    8. The Center for Ultrasound Research and Education (CURE) Receives Institutional Accreditation from the Accrediting Bureau of Health Education Schools
    9. OncoSec Medical Issues Letter to Shareholders
    10. Faruqi & Faruqi, LLP is Investigating Pain Therapeutics Inc. on Behalf of its Shareholders (PTIE)
    11. Amylin Pharmaceuticals, Inc. Shareholder Alert: Bernstein Liebhard LLP Announces Investigation Of Acquisition By Bristol-Myers Squibb Company
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:4/27/2015)... April 27, 2015 Numerous Zofran birth defects ... the U.S. have highlighted serious concerns surrounding the use ... According to the U.S. Centers for Disease Control ... the market have enough information to determine their safety ... expectant mothers in the U.S. take at least one ...
    (Date:4/27/2015)... NEW YORK , April 27, 2015   ... management solutions, will showcase advances in monitored care that ... the upcoming ATA 2015 Conference, May 2-5 ... Center. AMC Health will share information about ... monitored care to help transform and personalize healthcare delivery ...
    (Date:4/27/2015)... Pa. , April 27, 2015  SCILEX ... and commercialization of products focused on the treatment ... team of William Stewart and ... important steps in SCILEX,s proprietary drug development program ... its products. The Company,s first product, ZTlido™ (lidocaine ...
    Breaking Medicine Technology:Growing Zofran Birth Defects Litigation Highlights Concerns Surrounding Use of Prescription Medications During Pregnancy, According to Bernstein Liebhard LLP 2Growing Zofran Birth Defects Litigation Highlights Concerns Surrounding Use of Prescription Medications During Pregnancy, According to Bernstein Liebhard LLP 3AMC Health to Showcase Advances in Monitored Care at ATA 2015 2AMC Health to Showcase Advances in Monitored Care at ATA 2015 3AMC Health to Showcase Advances in Monitored Care at ATA 2015 4SCILEX Pharmaceuticals Announces Commercial Executive Appointments 2SCILEX Pharmaceuticals Announces Commercial Executive Appointments 3
    (Date:4/27/2015)... "Understanding Mental Disorders: Your Guide to the ... Psychiatric Publishing, a division of the American Psychiatric Association. ... National Press Club in Washington, D.C.. The launch event ... President Paul Summergrad, MD. Guest speakers will include Former ... the book; Paul Gionfriddo, President and CEO of Mental ...
    (Date:4/27/2015)... CA (PRWEB) April 27, 2015 On April ... to Get Rid of Stretch Marks ,” interviewed a ... marks . Stretch marks are a type of ... marks are caused by a breakdown of the elsastin and ... epidermis. (see: goo.gl/iRdmEe) , “Stretch mark removal with the ...
    (Date:4/27/2015)... Beckman Coulter is sponsoring a ... the evolution of neural circuitry and swimming behavior of ... mechanisms by which analogous forms of swimming behavior, such ... independently in certain sea slug clades. The webinar is ... 30, 2015 at 8:00am PT. , Sea slugs (Mollusca, ...
    (Date:4/27/2015)... (PRWEB) April 27, 2015 Sitting or standing ... ache and feel tired, and for those whose occupation requires ... receptionists and taxi cab drivers, or to be on their ... hairdressers, the discomfort can be more severe and longer lasting. ... leg syndrome. Dr. Madaiah Revana of Northeast Houston Vein Center ...
    (Date:4/27/2015)... FMC Corporation’s Health and Nutrition business announced ... market leading ingredients and solutions at Vitafoods Europe from ... Europe 2015 expects to host 14,000 attendees and 750 ... in such areas as digestive health, heart health, healthy ... Nutrition’s booth will feature its world leading Epax® brand ...
    Breaking Medicine News(10 mins):Health News:American Psychiatric Association, Patrick Kennedy To Debut New Consumer Guidebook “Understanding Mental Disorders” 2Health News:Stretch Marks: The Latest Treatment Options for Stretch Mark Removal 2Health News:Beckman Coulter Genomics Presents Using Next-Gen Sequencing to Study the Evolution of Neural Circuitry 2Health News:Beckman Coulter Genomics Presents Using Next-Gen Sequencing to Study the Evolution of Neural Circuitry 3Health News:Northeast Houston Vein Center Offers Tips on How to Treat Achy Legs 2Health News:Northeast Houston Vein Center Offers Tips on How to Treat Achy Legs 3Health News:FMC Health and Nutrition to Feature Epax® Brand Omega-3 Ingredients at Vitafoods Europe 2015 2
    ... The developer of a product, known as ALKA-V6, a ... research as a potential cancer fighting weapon, has been named ... Arts at Texas State University. , Ignacius Cisneros, of Odessa, ... Alumni and business leaders. , In inviting Cisneros to participate, ...
    ... ... their shut-off products in an industrial gray color. , ... Loveland, CO (Vocus) October 30, 2009 -- Kent Systems is now ... offered were in patriotic red, white, and blue as well as black. The color selections ...
    ... , ... analyzes myths concerning alpine skiing injuries , ... Rosemont, IL (Vocus) October 30, 2009 -- Alpine skiing is ... crash videos replayed during the evening sports casts. However, a new study published in ...
    ... Findings from a new retrospective cohort study presented at ... in San Diego indicate that patients with Inflammatory Bowel ... medications to treat IBD, may be at risk for ... of the University of North Carolina, Chapel Hill, and ...
    ... ... increase the efficiency of inactivating 99.9% of the flu virus. The filter has been ... extracts. , ... CA (PRWEB) October 29, 2009 -- Coway ,s new anti-flu air filter ...
    ... 29 The Ensign Group, Inc. (Nasdaq: ENSG ... skilled nursing, rehabilitative care services, hospice care and assisted ... the Oppenheimer & Co. 20th Annual Healthcare Conference on ... (Logo: http://www.newscom.com/cgi-bin/prnh/20071213/LATH168LOGO ) , Christopher Christensen, the ...
    Cached Medicine News:Health News:Texas State University Names Developer of ALKA-V6 Compound to Board of Advisors 2Health News:Skiing Not As Dangerous as Believed 2Health News:Skiing Not As Dangerous as Believed 3Health News:Skiing Not As Dangerous as Believed 4Health News:Study reveals possible link between IBD therapy and skin cancer 2Health News:Coway Announces New Anti-Flu Air Filter Can Inactivate 2009 Seasonal Flu Virus 2Health News:The Ensign Group to Present at Oppenheimer 20th Annual Healthcare Conference 2
    Double Ended Occluders...
    Long handle occluders are approximately 9 inches long....
    Manual Lensmeter....
    Lightweight, cordless lensmeter....
    Medicine Products: